Also heard from Resmed at the conference: Farrell characterized a decision by the Centers for Medicare & Medicaid Services (CMS) to not include CPAP devices and supplies in the next round of its competitive bidding program as a great win for the industry. If you look over the last 15 years, the differential price between what the government is paying for our therapy and what private pay (is paying), 15 years ago, there was a big delta, he said
Most brands cut corners on at least one of those
An evaluation of the etiological factors of lymphedema following radical mastectomy
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K (2015) Notch signaling: an emerging therapeutic target for cancer treatment
This means it's still too early to press the small cap/low quality/deep cyclical rotation trade until the Fed shows a clear willingness to get ahead of the curve
Advanced IV therapies include treatments such as NAD+ infusions or specialized recovery blends with longer infusion times and higher ingredient costs